David Cherba

1.4k total citations
25 papers, 978 citations indexed

About

David Cherba is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, David Cherba has authored 25 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in David Cherba's work include Sarcoma Diagnosis and Treatment (4 papers), Virus-based gene therapy research (3 papers) and Computational Drug Discovery Methods (3 papers). David Cherba is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Virus-based gene therapy research (3 papers) and Computational Drug Discovery Methods (3 papers). David Cherba collaborates with scholars based in United States, Australia and Russia. David Cherba's co-authors include Craig P. Webb, William F. Punch, Simon J. L. Billinge, Pavol Juhás, Phillip M. Duxbury, Tom Mikkelsen, Laila Poisson, Ana C. deCarvalho, Mary E. Winn and Yuri Nikolsky and has published in prestigious journals such as Nature, Nature Genetics and PLoS ONE.

In The Last Decade

David Cherba

23 papers receiving 957 citations

Peers

Countries citing papers authored by David Cherba

Since Specialization

Citations

This map shows the geographic impact of David Cherba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cherba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cherba more than expected).

Fields of papers citing papers by David Cherba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cherba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cherba. The network helps show where David Cherba may publish in the future.

Co-authorship network of co-authors of David Cherba

This figure shows the co-authorship network connecting the top 25 collaborators of David Cherba. A scholar is included among the top collaborators of David Cherba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Cherba. David Cherba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma 2018 ·Nature Genetics ·Ana C. deCarvalho, Hoon Kim, Laila Poisson, Mary E. Winn, Claudius Mueller, David Cherba, Julie Koeman, Sahil Seth, Alexei Protopopov, Michelle M. Felicella, (unknown), Asha S. Multani, Yongying Jiang, Jianhua Zhang, Do‐Hyun Nam, Emanuel F. Petricoin, Lynda Chin, Tom Mikkelsen, Roel G.W. Verhaak	176
2	Abstract B19: MET and IL6 signaling in triple-negative breast cancer 2016 ·Molecular Cancer Research ·Elizabeth A. Tovar, Mansoureh Sameni, Curt J. Essenburg, (unknown), (unknown), David Cherba, (unknown), Mary E. Winn, Bonnie F. Sloane, Carrie R. Graveel	1
3	Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models 2015 ·Clinical Cancer Research ·Mansoureh Sameni, Elizabeth A. Tovar, Curt J. Essenburg, (unknown), (unknown), Andrew Borgman, David Cherba, Arulselvi Anbalagan, Mary E. Winn, Carrie R. Graveel, Bonnie F. Sloane	45
4	Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling 2015 ·Journal of Translational Medicine ·Jessica Foley, Donald J. Scholten, Noel R. Monks, David Cherba, David J. Monsma, (unknown), (unknown), Karl Dykema, Mary E. Winn, Matthew R. Steensma	20
5	Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms. 2015 ·PubMed ·David J. Monsma, David Cherba, Emily Eugster, (unknown), (unknown), (unknown), Andrew Borgman, Mary E. Winn, Karl Dykema, Craig P. Webb, Jeffrey P. MacKeigan, Nicholas S. Duesbery, Brian J. Nickoloff, Noel R. Monks	21
6	Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance 2014 ·Pediatric Blood & Cancer ·David J. Monsma, David Cherba, (unknown), Sean Vance, (unknown), (unknown), Emily Eugster, (unknown), (unknown), (unknown), Richard A. Axtell, Deanna Mitchell, Eric P. Lester, Joseph Junewick, Craig P. Webb, Noel R. Monks	16
7	Mesenchymal‐like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial‐like counterparts 2014 ·Molecular Oncology ·(unknown), David Cherba, (unknown), Elizabeth Lenkiewicz, Lisa Evers, Michael T. Barrett, Brian B. Haab	6
8	Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation 2014 ·Neoplasia ·(unknown), Laila Poisson, David Cherba, Craig P. Webb, (unknown), Nancy Lemke, Hong Xin, Laura Hasselbach, Susan M. Irtenkauf, Tom Mikkelsen, Ana C. deCarvalho	123
9	Prospective Molecular Profiling of Canine Cancers Provides a Clinically Relevant Comparative Model for Evaluating Personalized Medicine (PMed) Trials 2014 ·PLoS ONE ·Melissa Paoloni, Craig P. Webb, Christina Mazcko, David Cherba, William P.D. Hendricks, Susan E. Lana, E. J. Ehrhart, (unknown), (unknown), (unknown), David M. Vail, Michael S. Henson, Michael O. Childress, Barbara E. Kitchell, Christopher Kingsley, Seungchan Kim, Mark W. Neff, Barbara J. Davis, Chand Khanna, Jeffrey M. Trent	26
10	Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors 2013 ·Journal of Translational Medicine ·Jacqueline D. Peacock, David Cherba, (unknown), (unknown), Noel R. Monks, Craig P. Webb, Matthew R. Steensma	14
11	Comparative RNA-Seq and Microarray Analysis of Gene Expression Changes in B-Cell Lymphomas of Canis familiaris 2013 ·PLoS ONE ·Marie R. Mooney, Jeffrey P. Bond, Noel R. Monks, Emily Eugster, David Cherba, (unknown), (unknown), Keith R. Marotti, (unknown), (unknown), Waibhav Tembe, Christophe Legendre, Hollie Benson, Winnie S. Liang, Craig P. Webb	47
12	A Pilot Trial Testing the Feasibility of Using Molecular-Guided Therapy in Patients with Recurrent Neuroblastoma 2012 ·Journal of Cancer Therapy ·Giselle L. Saulnier Sholler, William S. Ferguson, Genevieve Bergendahl, Erika A. Currier, (unknown), Jeffrey P. Bond, (unknown), William Roberts, Deanna Mitchell, Don Eslin, Jacqueline M. Kraveka, Joel A. Kaplan, Nehal S. Parikh, Suman Malempati, (unknown), Emily Eugster, David Cherba, J. Miller, Craig P. Webb	12
13	Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue 2012 ·Journal of Translational Medicine ·David J. Monsma, Noel R. Monks, David Cherba, (unknown), Emily Eugster, (unknown), Sujata Srikanth, (unknown), (unknown), Robin E. Everts, (unknown), Yuri Nikolsky, James H. Resau, Robert E. Sigler, Brian J. Nickoloff, Craig P. Webb	55
14	MEK2 Is Sufficient but Not Necessary for Proliferation and Anchorage-Independent Growth of SK-MEL-28 Melanoma Cells 2011 ·PLoS ONE ·Chih-Shia Lee, Karl Dykema, (unknown), David Cherba, Craig P. Webb, Kyle A. Furge, Nicholas S. Duesbery	21
15	MicroRNA 92a-2: A Biomarker Predictive for Chemoresistance and Prognostic for Survival in Patients with Small Cell Lung Cancer 2010 ·Journal of Thoracic Oncology* ·Aarati R. Ranade, David Cherba, Shravan Sridhar, (unknown), Craig P. Webb, (unknown), (unknown), Glen J. Weiss	105
16	Identifying disease-specific genes based on their topological significance in protein networks 2009 ·BMC Systems Biology ·Zoltán Dezső, Yuri Nikolsky, Tatiana Nikolskaya, J. Miller, David Cherba, Craig P. Webb, Andrej Bugrim	91
17	Ab initio determination of solid-state nanostructure 2006 ·Nature ·Pavol Juhás, David Cherba, Phillip M. Duxbury, William F. Punch, Simon J. L. Billinge	148
18	Ab initio Determination of Solid‐State Nanostructure. 2006 ·ChemInform ·Pavol Juhás, David Cherba, P. M. Duxbury, William F. Punch, Simon J. L. Billinge	0
19	Crossover gene selection by spatial location 2006 ·David Cherba, William F. Punch	7
20	Parallelizing Solid Particles in Lattice-Boltzmann Fluid Dynamics 2002 ·Parallel and Distributed Processing Techniques and Applications ·(unknown), (unknown), David Cherba, Dewei Qi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact